Bempedoic acid for fatty liver in type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if bempedoic acid, a cholesterol-lowering drug, can reduce liver fat in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help those who have stable blood sugar and are not on certain other medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older with type 2 diabetes for at least 3 months
- Your blood sugar (HbA1c) is under 9% on your current diabetes medications
- You have a fatty liver confirmed by an MRI scan (with liver fat over 5.6%)
- You have not taken certain diabetes drugs (like SGLT2 inhibitors, GLP-1 agonists) or weight loss medications in the past 3 months
- You do not have severe kidney disease, heart problems within the last 3 months, or a history of alcohol or drug abuse
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two diabetes pills (pioglitazone and empagliflozin) to see if they can reduce liver fat in people with type 2 diabetes and fatty liver disease. It may help if your diabetes is not well controlled and you have a fatty liver confirmed by a special ultrasound scan.
This study looks at how the liver uses energy (mitochondria) in people with type 2 diabetes and fatty liver disease. By understanding this, researchers may find better ways to treat liver problems.
This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.
This study tests whether bempedoic acid, a new cholesterol-lowering medication, can help people with heart disease or very high cholesterol. You'd take it along with your current cholesterol medications to see if it further reduces your cholesterol levels and protects your heart.
This trial tests a new medicine called bempedoic acid compared to statins for people who have trouble sticking with statins. It looks at how well each medicine lowers 'bad' cholesterol and how well they are tolerated.
This study is checking how well people stick with taking bempedoic acid, a cholesterol-lowering medication, and how effective it is over time.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.